321674-73-1

  • Product Name:BIBR1532
  • Molecular Formula:C21H17NO3
  • Molecular Weight:331.36
Inquiry

Product Details

Purity:99%

Chinese factory supply BIBR1532 321674-73-1 in stock with high standard

  • Molecular Formula:C21H17NO3
  • Molecular Weight:331.36
  • Vapor Pressure:0mmHg at 25°C 
  • Refractive Index:1.698 
  • Boiling Point:600.607 °C at 760 mmHg 
  • PKA:3.46±0.36(Predicted) 
  • Flash Point:317.036 °C 
  • PSA:66.40000 
  • Density:1.285 g/cm3 
  • LogP:4.65300 

2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID(Cas 321674-73-1) Usage

Biological Activity

Selective telomerase inhibitor (IC 50 values are 93, > 100000 and > 100000 nM for human telomerase, human RNA polymerase I and human RNA polymerase II + III respectively). Causes telomere shortening in exponentially growing NCI-H460 lung carcinoma cells and eventual growth arrest.

references

[1]. damm, k.; hemmann, u.; garin-chesa, p.; hauel, n.; kauffman, i.; priepke, h.; niestroj, c.; daiber, c.; enenkel, b.; guilliard, b.; lauritsch, i.; muller, e.; pascolo, e.; sauter, g.; pantic, m.; martens, u. m.; wenz, c.; linger, j.; kraut, n.; rettig, w. j.;schnapp, a. a highly selective telomerase inhibitor limiting human cancer cell proliferation. embo j. 2001, 20, 6958?6968.[2]. bashash d1, ghaffari sh, mirzaee r, alimoghaddam k, ghavamzadeh a. telomerase inhibition by non-nucleosidic compound bibr1532 causes rapid cell death in pre-b acute lymphoblastic leukemia cells. leuk lymphoma. 2013 mar;54[4]:561-8. doi: 10.3109/10428194.2012.704034. epub 2012 sep 28.[3]. bashash d1, ghaffari sh, zaker f, kazerani m, hezave k, hassani s, rostami m, alimoghaddam k, ghavamzadeh a. anticancer agents med chem. 2013 sep;13(7):1115-25. bibr 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for apl.

InChI:InChI=1/C21H17NO3/c1-14(16-11-10-15-6-2-3-7-17(15)13-16)12-20(23)22-19-9-5-4-8-18(19)21(24)25/h2-13H,1H3,(H,22,23)(H,24,25)/b14-12+

321674-73-1 Relevant articles

TELOMERASE REVERSE TRANSCRIPTASE DEGRADERS AND METHODS OF USE THEREOF

-

Paragraph 00127; 00128, (2020/12/30)

The present disclosure provides TERT inh...

N-substituted acrylamide derivatives as DHODH inhibitors and preparation and use of N-substituted acrylamide derivatives

-

Paragraph 0178-0179; 0183; 0320-0322, (2019/11/04)

The invention relates to N-substituted a...

Inhibition of telomerase by BIBR 1532 and related analogues

Barma,Elayadi, Anissa,Falck,Corey, David R.

, p. 1333 - 1336 (2007/10/03)

BIBR 1532 has been reported to be a pote...

Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use

-

, (2008/06/13)

Carboxylic acid amides of general formul...

321674-73-1 Process route

N-(2-carbomethoxyphenyl)-3-(naphthalen-2-yl)-but-2(Z)-enamide
565190-73-0

N-(2-carbomethoxyphenyl)-3-(naphthalen-2-yl)-but-2(Z)-enamide

trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide
321674-73-1

trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide

Conditions
Conditions Yield
With lithium hydroxide; In tetrahydrofuran; at 20 ℃; for 12h;
With sodium hydroxide; In ethanol;
N-(2-carbomethoxyphenyl)-3-(naphthalen-2-yl)-but-2(E)-enamide
321674-72-0

N-(2-carbomethoxyphenyl)-3-(naphthalen-2-yl)-but-2(E)-enamide

2-[[(2E)-3-(2-naphthalenyl)-1-oxo-2-butenyl-1-yl]amino]benzoic acid
321674-73-1

2-[[(2E)-3-(2-naphthalenyl)-1-oxo-2-butenyl-1-yl]amino]benzoic acid

Conditions
Conditions Yield
With lithium hydroxide; In tetrahydrofuran; at 20 ℃; for 12h;
With water; lithium hydroxide; In tetrahydrofuran; methanol;

321674-73-1 Upstream products

  • 565190-73-0
    565190-73-0

    N-(2-carbomethoxyphenyl)-3-(naphthalen-2-yl)-but-2(Z)-enamide

  • 51212-51-2
    51212-51-2

    methyl (Z)-3-(naphthalen-2-yl)-but-2-enoate

  • 93-08-3
    93-08-3

    methyl 2-naphthyl ketone

  • 321674-72-0
    321674-72-0

    N-(2-carbomethoxyphenyl)-3-(naphthalen-2-yl)-but-2(E)-enamide

Relevant Products